Showing results (331-340 of 344) with videos related to
Sort By:
Pageof 35
Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.Journal of Hepatology|June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.Journal of Hepatology|November 26, 2018
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D'Ambrosio, Luisa Pasulo, Massimo Puoti, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2020
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohortAlessandro Soria, Marco Fava, Davide P Bernasconi, et al.Pageof 35